Overweight Archives - PharmaLive

Boehringer Ingelheim Launches Weight-Loss Trials for NASH

Antibiotic resistance, Boehringer Ingelheim, Business, Clinical Trials, Glucagon, Glucagon-Like Peptide-1 (GLP-1) Analogs, Infusions, Lyme Disease, Non-alcoholic steatohepatitis (NASH), Obesity, Overweight, Partnerships, R&D

Germany’s Boehringer Ingelheim partnered with Denmark’s Zealand Pharma A/S to study the GLP-1/glucagon dual agonist BI 456906 in two Phase II trials as a potential treatment for adults who are overweight or obese and for adults with non-alcoholic steatohepatitis (NASH).

Strides in lung cancer lead steep decline in U.S. cancer deaths

American Cancer Society, Breast Cancer, Cancer Deaths, Colorectal Cancer, Lung Cancer, Mortality Data, Mortality rates, National Cancer Institute, Obesity, Overweight, Prostate Cancer, United States

Cancer deaths in the United States fell 2.2% from 2016 to 2017 – the largest single-year drop ever recorded – fueled in large part by progress against lung cancer, the leading cause of cancer death, the American Cancer Society (ACS) reported.

Eisai Announces Positive Topline Results from Large-Scale Cardiovascular Outcome Trial for Anti-Obesity Agent Belviq

Cardiovascular Outcomes, Clinical Trials, FDA, Obesity, Overweight, Sleep Apnea, Weight

Eisai Inc. announced positive top-line results from the CAMELLIA-TIMI 61 cardiovascular outcome trial.